Image Credit: Love Employee / Shutterstock In a recent observational study published online as an unedited 'Article in Press' in the journal Scientific Reports , researchers at the University of California, San Francisco, reported that semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA) used to treat type 2 diabetes and manage weight in people with obesity or overweight, was associated with a lower hazard of coronavirus disease 2019 (COVID-19)-related death, consistent with previous findings
A sublingual dose of 1mg does not produce the same blood levels as an injectable dose of 1mg
Why Compounding Exists (Drug Shortages, Dose Customization, Cost) Compounding serves several important healthcare purposes, and understanding why it exists helps contextualize its role in the GLP-1 medication space
Type 2 Diabetes Mellitus: A Review of Current Trends, Oman Med J
The decision depends on response, tolerance, and goals
Echelon Biosciences has over 28 years of experience working with lipids